GB9103824D0 - Formulation - Google Patents
FormulationInfo
- Publication number
- GB9103824D0 GB9103824D0 GB919103824A GB9103824A GB9103824D0 GB 9103824 D0 GB9103824 D0 GB 9103824D0 GB 919103824 A GB919103824 A GB 919103824A GB 9103824 A GB9103824 A GB 9103824A GB 9103824 D0 GB9103824 D0 GB 9103824D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- formulation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Otolaryngology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
Priority Applications (13)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB919103824A GB9103824D0 (en) | 1991-02-23 | 1991-02-23 | Formulation |
IE051692A IE920516A1 (en) | 1991-02-23 | 1992-02-18 | Steroid Formulations |
GR920100064A GR1001511B (en) | 1991-02-23 | 1992-02-18 | Steroid formulations. |
AU12471/92A AU1247192A (en) | 1991-02-23 | 1992-02-19 | Steroid formulations |
IL101010A IL101010A0 (en) | 1991-02-23 | 1992-02-19 | Steroid pharmaceutical formulations |
PCT/GB1992/000290 WO1992014473A1 (en) | 1991-02-23 | 1992-02-19 | Steroid formulations |
ZA921247A ZA921247B (en) | 1991-02-23 | 1992-02-20 | Steroid formulations |
ITMI920393A IT1254627B (en) | 1991-02-23 | 1992-02-21 | Steroid formulations |
BE9200182A BE1004177A4 (en) | 1991-02-23 | 1992-02-21 | Steroid compositions. |
PT100150A PT100150A (en) | 1991-02-23 | 1992-02-21 | FORMULATIONS CONTAINING STEROIDS |
MX9200748A MX9200748A (en) | 1991-02-23 | 1992-02-21 | STEROID FORMULATIONS. STEROID FORMULATIONS. |
CN92101619A CN1065010A (en) | 1991-02-23 | 1992-02-22 | The compositions of steroid |
FR9202105A FR2673104A1 (en) | 1991-02-23 | 1992-02-24 | PHARMACEUTICAL COMPOSITIONS OF AQUEOUS SUSPENDED ANTI-INFLAMMATORY STEROUID FOR NASAL ADMINISTRATION |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB919103824A GB9103824D0 (en) | 1991-02-23 | 1991-02-23 | Formulation |
Publications (1)
Publication Number | Publication Date |
---|---|
GB9103824D0 true GB9103824D0 (en) | 1991-04-10 |
Family
ID=10690478
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB919103824A Pending GB9103824D0 (en) | 1991-02-23 | 1991-02-23 | Formulation |
Country Status (13)
Country | Link |
---|---|
CN (1) | CN1065010A (en) |
AU (1) | AU1247192A (en) |
BE (1) | BE1004177A4 (en) |
FR (1) | FR2673104A1 (en) |
GB (1) | GB9103824D0 (en) |
GR (1) | GR1001511B (en) |
IE (1) | IE920516A1 (en) |
IL (1) | IL101010A0 (en) |
IT (1) | IT1254627B (en) |
MX (1) | MX9200748A (en) |
PT (1) | PT100150A (en) |
WO (1) | WO1992014473A1 (en) |
ZA (1) | ZA921247B (en) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0551626A1 (en) * | 1991-12-19 | 1993-07-21 | LEK, tovarna farmacevtskih in kemicnih izdelkov, d.d. | Thermoreversible gel as a liquid pharmaceutical carrier for a galenic formulation |
US5976573A (en) * | 1996-07-03 | 1999-11-02 | Rorer Pharmaceutical Products Inc. | Aqueous-based pharmaceutical composition |
JP2005281315A (en) * | 1997-07-02 | 2005-10-13 | Aventis Pharmaceuticals Holdings Inc | Aqueous pharmacological composition |
TWI243687B (en) | 1998-04-21 | 2005-11-21 | Teijin Ltd | Pharmaceutical composition for application to mucosa |
US20030059440A1 (en) * | 1998-09-01 | 2003-03-27 | Tim Clarot | Composition and method for moisturizing nasal tissue |
AR026073A1 (en) | 1999-10-20 | 2002-12-26 | Nycomed Gmbh | PHARMACEUTICAL COMPOSITION AQUATIC CONTAINING CICLESONIDE |
AR026072A1 (en) * | 1999-10-20 | 2002-12-26 | Nycomed Gmbh | PHARMACEUTICAL COMPOSITION CONTAINING CICLESONIDE FOR MUCOSA APPLICATION |
DE10064950A1 (en) * | 2000-12-23 | 2002-07-11 | Impetus Ag Basel | Thixotropic nasal spray |
EP1645266A1 (en) * | 2004-10-08 | 2006-04-12 | Hisamitsu Medical Co., Ltd. | Aqueous suspension for nasal drops |
EP2057982A1 (en) * | 2007-11-09 | 2009-05-13 | Archimedes Development Limited | Intranasal compositions |
WO2013049539A1 (en) * | 2011-09-30 | 2013-04-04 | Mcneil-Ppc, Inc. | A method of blocking or trapping allergens |
EP3694524A1 (en) * | 2017-10-11 | 2020-08-19 | Lifescience AS | N-acetylneuraminic acid compositions and methods of use |
WO2020165578A1 (en) * | 2019-02-11 | 2020-08-20 | Reckitt Benckiser Health Limited | Novel composition |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4361559A (en) * | 1981-08-20 | 1982-11-30 | E. R. Squibb & Sons, Inc. | Antiinflammatory 17,17-bis (substituted thio) androstenes |
US4782047A (en) * | 1986-05-22 | 1988-11-01 | Syntex Pharmaceuticals International Ltd. | Aqueous steroid formulations for nasal administration |
US4868170A (en) * | 1987-11-13 | 1989-09-19 | E. R. Squibb & Sons, Inc. | Steriod lotion formulation |
IL97065A (en) * | 1990-02-02 | 1994-01-25 | Fisons Plc | Aerosol propellant compositions |
-
1991
- 1991-02-23 GB GB919103824A patent/GB9103824D0/en active Pending
-
1992
- 1992-02-18 IE IE051692A patent/IE920516A1/en unknown
- 1992-02-18 GR GR920100064A patent/GR1001511B/en unknown
- 1992-02-19 AU AU12471/92A patent/AU1247192A/en not_active Abandoned
- 1992-02-19 WO PCT/GB1992/000290 patent/WO1992014473A1/en active Application Filing
- 1992-02-19 IL IL101010A patent/IL101010A0/en unknown
- 1992-02-20 ZA ZA921247A patent/ZA921247B/en unknown
- 1992-02-21 MX MX9200748A patent/MX9200748A/en unknown
- 1992-02-21 BE BE9200182A patent/BE1004177A4/en not_active IP Right Cessation
- 1992-02-21 PT PT100150A patent/PT100150A/en not_active Application Discontinuation
- 1992-02-21 IT ITMI920393A patent/IT1254627B/en active IP Right Grant
- 1992-02-22 CN CN92101619A patent/CN1065010A/en active Pending
- 1992-02-24 FR FR9202105A patent/FR2673104A1/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
FR2673104A1 (en) | 1992-08-28 |
ZA921247B (en) | 1992-10-28 |
CN1065010A (en) | 1992-10-07 |
WO1992014473A1 (en) | 1992-09-03 |
ITMI920393A1 (en) | 1993-08-21 |
PT100150A (en) | 1993-05-31 |
BE1004177A4 (en) | 1992-10-06 |
GR1001511B (en) | 1994-02-28 |
AU1247192A (en) | 1992-09-15 |
MX9200748A (en) | 1992-10-01 |
IT1254627B (en) | 1995-09-28 |
ITMI920393A0 (en) | 1992-02-21 |
IE920516A1 (en) | 1992-08-26 |
IL101010A0 (en) | 1992-11-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB9118028D0 (en) | Improved transdrmal formulations | |
GB9207832D0 (en) | Formulations | |
GB2252389B (en) | Autotensioner | |
GB9103824D0 (en) | Formulation | |
GB9221883D0 (en) | Novel formulation | |
GB9110675D0 (en) | Mopheads | |
GB9108128D0 (en) | Novel formulation | |
GB9108281D0 (en) | Formulation | |
GB9125953D0 (en) | Formulation | |
GB9120675D0 (en) | Formulation | |
GB9104946D0 (en) | Formulation | |
GB9126687D0 (en) | Novel formulation | |
GB9011851D0 (en) | Formulation | |
GB9025762D0 (en) | Formulation | |
ZW10390A1 (en) | Formulation | |
GB9012919D0 (en) | Formulation | |
GB9008591D0 (en) | Formulation | |
GB9003965D0 (en) | Formulation | |
ZA928061B (en) | Lipomimetic formulation | |
GB9202110D0 (en) | Formulation | |
GB9205183D0 (en) | Formulation | |
GB9217322D0 (en) | Formulation | |
GB9225583D0 (en) | Formulation | |
GB9201915D0 (en) | Formulation | |
GB9105373D0 (en) | Formulations |